MDR1 in paroxetine-induced sexual dysfunction

Journal of Sex and Marital Therapy

Volumn 39, Issue 1, 2013, Pages 71-78

  Žourková, Alexandra ^a   Slana, Ondej ^b   Jarkovsk, Ji ^a   Palková, Ivana ^a   Pindurová, Eva ^a   Cvanová, Michaela ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ABCB1 PROTEIN, HUMAN; ANTIDEPRESSANT AGENT; MULTIDRUG RESISTANCE PROTEIN;

ADULT; ANXIETY DISORDER; ARTICLE; BULIMIA; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MIDDLE AGED; MUTATION; PSYCHOSEXUAL DISORDER;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; BULIMIA NERVOSA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; MUTATION; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84870236418     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/0092623X.2012.668514     Document Type: Article

References (7)

1. Cascorbi, I., Gerloff, T., Johne, A., Meisel, C., Hoffmeyer, S., Schwab, M., .Roots, I. (2001). Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in White subjects. Clinical Pharmacology & Therapeutics, 69, 169-174. (Pubitemid 32225417)
2. Lingjaerde, O., Ahlfors, V. G., Dencker, S. J., & Elgen, K. (1987). The UKU side effects rating scale for psychotropic drugs and a cross sectional study of side effects in antipsychotic patients. Acta Psychiatrica Scandinavica, 76, 1-100. (Pubitemid 17115352)
3. Loscher, W., & Potschka, H. (2005). Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. Journal of the American Society for Experimental NeuroTherapeutics, 2, 86-98. (Pubitemid 40128029)
4. Peles, M. A., Bozina, N., Sagud, M., Rojnic Kuzman, M., & Lovric, M. (2008). MDR1 gene polymorphism: Therapeutic response to paroxetine among patients with major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32, 1439-1444.
5. Segraves R. T., & Balon, R. (2003). Sexual pharmacology: Fast facts. New York, NY: Norton.
6. Siegmund, W., Ludwig, K., Giessmann, T., Dazert, P., Schroeder, E., Sperker, B., .Cascorbi, I. (2002). The effects of the human MDR1 genotype on the expression of duodenal pglycoprotein and disposition of the probe drug talinolol. Clinical Pharmacology & Therapeutics, 72, 572-583. (Pubitemid 36237729)
7. World Health Organization. (1992). International classification of mental and behavioural disorders. Geneva, Switzerland: Author.